Literature DB >> 36271198

Risk Factors for Chronic Atrial Fibrillation Development After Esophagectomy for Esophageal Cancer.

Manabu Kashiwagi1, Toshiyasu Ojima2, Keiji Hayata3, Junya Kitadani3, Akihiro Takeuchi3, Akio Kuroi1, Kosei Terada1, Takashi Tanimoto1, Atsushi Tanaka1, Hiroki Yamaue3.   

Abstract

BACKGROUND: This study investigates the prognosis of patients with postoperative atrial fibrillation (POAF), aiming to elucidate predictors of occurrence of atrial fibrillation (AF) in the chronic phase after esophagectomy.
METHODS: We retrospectively analyzed 415 consecutive patients between July 2010 and December 2021 who were scheduled to undergo esophagectomy for esophageal cancer and had no previous history of AF.
RESULTS: POAF occurred in 73 patients (18%). Their ages were higher than those without POAF (72 [66-77] vs 68 [62-75], P < 0.01). Three-field lymph node dissection was more frequent in patients with POAF (63% vs 50%, P = 0.04). Overall survival rates were not significantly different between those with and without POAF in patients with stage III/IV cancer (P = 0.37), but overall survival rate of patients with POAF was lower than in those without POAF in stage I/II cancer (P = 0.03). Seventeen patients (4.1%) had recurrence of AF or new onset 31 days after esophagectomy. POAF was the only independent predictor of AF development in the chronic phase (HR: 4.09, 95%CI: [1.42-11.74], P = 0.01). AF development in the chronic phase was observed in 8 patients (11.0%) with and 9 patients (2.6%) without POAF (P < 0.01). AF development rates were not significantly different in patients with stage III/IV cancer (P = 0.05), but there was significant difference in patients with stage I/II cancer (P < 0.01).
CONCLUSION: The occurrence of POAF after esophagectomy is related with future development of AF and overall survival prognosis. Future studies must ascertain optimal therapeutic strategy.
© 2022. The Society for Surgery of the Alimentary Tract.

Entities:  

Keywords:  Atrial fibrillation; Esophageal cancer; Prognosis

Year:  2022        PMID: 36271198     DOI: 10.1007/s11605-022-05493-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  1 in total

Review 1.  Atrio-Esophageal Fistula After AF Ablation: Pathophysiology, Prevention &Treatment.

Authors:  Carlo Pappone; Gabriele Vicedomini; Vincenzo Santinelli
Journal:  J Atr Fibrillation       Date:  2013-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.